HRYZ Biotech Co. Report issue

For profit Phase 1
Founded: ShenZhen China (2013)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2017
NCT03034304
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now